On Thursday, in the course of Afternoon trade, Shares of NCR Corporation (NYSE:NCR), dropped -0.48%, and is now trading at $26.98.
NCR Corporation, reported (The Forrester Wave: Point of Service, Q3 2015). Forrester Research, Inc., a global research and advisory firm, evaluated 10 top point-of-service companies against 59 criteria across three categories: “current offering,” “strategy” and “market presence.” In each category, Forrester scored criteria such core POS, product vision, security, international capabilities and geographic deployment.
NCR Corporation, a technology company, provides solutions and services that enable businesses to connect, interact, and transact with their customers worldwide. The company operates through four segments: Financial Services, Retail Solutions, Hospitality, and Emerging Industries.
During an Afternoon trade, Shares of News Corp (NASDAQ:NWSA), dipped -5.07%, and is now trading at $13.86.
HarperCollins Publishers, a partner of News Corp (NWS)(NWSA)(NWS.AX)(NWSLV.AX) and joint venture partner Ediouro Group, declared the formation of HarperCollins Brasil, which combines the existing operations of Thomas Nelson Brasil and Harlequin Brasil with Ediouro’s commercial trade publishing titles and personnel.
HarperCollins Brasil will publish a select list of about 350 titles per year from the HarperCollins trade, children’s, Christian and romance imprints from around the world, in addition to a focused list of Brazilian authors. The new structure aligns Brazil with the HarperCollins strategy to build on existing infrastructures and relationships to grow its authors’ international presence and publish outside of the English language, as has been done in Germany, Poland, Nordic, Holland, Japan and Spain.
News Corporation, a media and information services company, focuses on creating and distributing authoritative and engaging content to consumers and businesses worldwide. The company operates through News and Information Services, Cable Network Programming, Digital Real Estate Services, Book Publishing, and Digital Education segments.
Shares of PDL BioPharma Inc (NASDAQ:PDLI), during its Thursday’s current trading session fell -2.59%, and is now trading at $5.65.
PDL BioPharma, stated financial results for the second quarter and six months ended June 30, 2015.
Total revenues were $138.1 million for the three months ended June 30, 2015, contrast to $162.8 million for the same period of 2014, and $287.8 million for the six months ended June 30, 2015, contrast to $299.6 million for the six months ended June 30, 2014. During the three and six months ended June 30, 2015 and 2014, our Queen et al. royalty revenues compriseed of royalties and maintenance fees earned on sales of products under license agreements associated with our Queen et al. patents. During the three and six months ended June 30, 2015 and 2014, royalty rights - change in fair value compriseed of revenues associated with the change in fair value of our royalty right assets, primarily Depomed, Inc., The Regents of the University of Michigan, and Viscogliosi Brothers, LLC. Revenues for the quarter ended June 30, 2015 comprised of $116.9 million in royalty and license payments from PDL’s licensees to the Queen et al. patents, $12.2 million in net royalty payments from attained royalty rights and a change in fair value of the royalty rights assets, which comprised of about $1.2 million in net cash royalty rights payments, and $9.0 million in interest revenue from notes receivable debt financings to late-stage healthcare companies. Revenues for the six months ended June 30, 2015 comprised of $244.7 million in royalty and license payments from PDL’s licensees to the Queen et al. patents, $23.6 million in net royalty payments from attained royalty rights and a change in fair value of the royalty rights assets, which comprised of about $2.1 million in net cash royalty rights payments, and $19.5 million in interest revenue from notes receivable debt financings to late-state healthcare companies.
PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases.
Finally, Kraft Heinz Co (NASDAQ:KHC), lost -0.62% Thursday.
The Kraft Heinz Company is voluntarily recalling select code dates and manufacturing codes of Kraft Singles individually-wrapped slices due to the possibility that a thin strip of the individual packaging film may remain adhered to the slice after the wrapper has been removed. If the film sticks to the slice and is not removed, it could potentially cause a choking hazard.
The recall applies to 3-lb. and 4-lb. sizes of Kraft Singles American and White American pasteurized prepared cheese product with a Best When Used By Date of 29 DEC 15 through 04 JAN 16, followed by the Manufacturing Code S54 or S55.
The Kraft Heinz Company, through its auxiliaries, operates as a food and beverage company in North America and internationally. It primarily offers food and beverage products, counting cheese, meats, refreshment beverages, coffee, packaged dinners, refrigerated meals, snack nuts, dressings, ketchup, condiments and sauces, frozen food, soups, beans and pasta meals, infant nutrition, and other food and grocery products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
